Constitution
Released
Released
Announcement PDF
ASX Announcement
Constitution
SYDNEY Australia, 6 November 2024: Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the
Company) attaches a copy of its New Constitution.
As announced in the Company’s earlier release:
1. Resolution 9 - Adoption of New Constitution; and
2. Resolution 10 - Renewal of Proportional Takeover Provisions,
were approved by shareholders at today’s Annual General Meeting by special resolution.
This announcement has been approved for release by Recce Pharmaceuticals Board.
About Recce Pharmaceuticals Ltd
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives
designed to address the urgent global health problems of antibiotic-resistant superbugs and emerging viral
pathogens.
Recce’s anti-infective pipeline includes three patented, broad-spectrum, synthetic polymer anti-infectives:
RECCE® 327 (R327) as an intravenous and topical therapy that is being developed for the treatment of serious
and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria, including their
superbug forms; RECCE® 435 (R435) as an orally administered therapy for bacterial infections; and RECCE® 529
(R529) for viral infections. Through their multi-layered mechanisms of action, Recce’s anti-infectives have the
potential to overcome the processes utilised by bacteria and viruses to overcome resistance – a current challenge
facing existing antibiotics.
The World Health Organization (WHO) added R327, R435, and R529 to its list of antibacterial products in clinical
development for priority pathogens, recognising Recce’s efforts to combat antimicrobial resistance. The FDA
granted R327 Qualified Infectious Disease Product designation under the Generating Antibiotic Initiatives Now
(GAIN) Act, providing Fast Track Designation and 10 years of market exclusivity post approval. R327 is also
included on The Pew Charitable Trusts’ Global New Antibiotics in Development Pipeline as the sole synthetic
polymer and sepsis drug candidate in development.
Recce wholly owns its automated manufacturing, supporting current clinical trials. Recce’s anti-infective pipeline
aims to address synergistic, unmet medical needs by leveraging its unique technologies.
CORPORATIONS ACT 2001
CONSTITUTION
of
RECCE PHARMACEUTICALS LTD
ACN 124 849 065
Adopted by Special Resolution of the members on 6 November 2024.
CONTENTS
1.
INTERPRETATION ........................................................................................................................ 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
2.
SHARE CAPITAL AND VARIATION OF RIGHTS ....................................................................... 4
2.1
2.2
2.3
2.4
2.5
2.6
2.7
2.8
2.9
2.10
2.11
2.12
2.13
2.14
2.15
3.
Effect of this Clause ........................................................................................................ 7
Definitions ....................................................................................................................... 7
Minimum Shareholding ................................................................................................... 8
Sale of Listed Securities of Minority Member ................................................................. 8
Acceptance of Offer ........................................................................................................ 8
Appointment of Attorney ................................................................................................. 8
Transfer........................................................................................................................... 9
Proceeds of Sale ............................................................................................................ 9
Receipt of Proceeds ....................................................................................................... 9
Registration of Purchaser ............................................................................................... 9
Remedies Limited ........................................................................................................... 9
Cost of Sale of Listed Securities ................................................................................... 10
Exemption from clause 3 .............................................................................................. 10
Notice to Exempt .......................................................................................................... 10
Takeover Offer or Announcement ................................................................................ 10
Use by Company of Clause 3 ....................................................................................... 10
Notice to New Minority Members .................................................................................. 10
UNCERTIFICATED HOLDINGS AND ELECTRONIC TRANSFERS ......................................... 11
4.1
4.2
4.3
4.4
5.
Rights Attaching to Shares ............................................................................................. 4
Issue of Shares ............................................................................................................... 4
Share Options ................................................................................................................. 5
Variation of class rights................................................................................................... 5
Effect of share issue on class rights ............................................................................... 5
Preference Shares .......................................................................................................... 5
Recognition of Trusts ...................................................................................................... 5
Unregistered Interests .................................................................................................... 5
Share Certificates and Share Option Certificates ........................................................... 6
Section 1071H of the Corporations Act .......................................................................... 6
Commissions .................................................................................................................. 6
Restricted Securities ....................................................................................................... 6
Non-Issue or Cancellation of Certificate ......................................................................... 7
No Prohibition on Foreign Ownership ............................................................................. 7
Payment of Interest out of Capital .................................................................................. 7
MINIMUM SHAREHOLDING ......................................................................................................... 7
3.1
3.2
3.3
3.4
3.5
3.6
3.7
3.8
3.9
3.10
3.11
3.12
3.13
3.14
3.15
3.16
3.17
4.
Definitions ....................................................................................................................... 1
Interpretation ................................................................................................................... 3
Corporations Act Definitions ........................................................................................... 4
Status of Constitution...................................................................................................... 4
General Authorisation ..................................................................................................... 4
Displacement of Replaceable Rules ............................................................................... 4
Enforceability .................................................................................................................. 4
Jurisdiction ...................................................................................................................... 4
Electronic or Computerised Holding ............................................................................. 11
Statement of Holdings .................................................................................................. 11
Share Certificates ......................................................................................................... 11
Listing Rules ................................................................................................................. 11
LIEN ............................................................................................................................................. 11
i
5.1
5.2
5.3
5.4
5.5
5.6
5.7
5.8
5.9
5.10
6.
CALLS ON SHARES ................................................................................................................... 13
6.1
6.2
6.3
6.4
6.5
6.6
6.7
6.8
6.9
6.10
6.11
6.12
7.
Failure to Pay Call ........................................................................................................ 15
Forfeiture ...................................................................................................................... 15
Sale of Forfeited Shares ............................................................................................... 15
Continuing Liability ........................................................................................................ 16
Officer’s Statement Prima Facie Evidence ................................................................... 16
Procedures ................................................................................................................... 16
Listing Rules and ASX Settlement Operating Rules .................................................... 16
Waive ............................................................................................................................ 16
TRANSFER OF SHARES............................................................................................................ 16
8.1
8.2
8.3
8.4
8.5
8.6
8.7
8.8
8.9
8.10
8.11
8.12
8.13
8.14
8.15
9.
Calls .............................................................................................................................. 13
Payment of Calls ........................................................................................................... 14
Quoted Shares .............................................................................................................. 14
Unquoted Shares .......................................................................................................... 14
Joint Liability ................................................................................................................. 14
Deemed Calls ............................................................................................................... 14
Differentiation between Shareholders .......................................................................... 14
Payments in Advance of Calls ...................................................................................... 14
Outstanding Moneys ..................................................................................................... 15
Revocation/Postponement or Extension ...................................................................... 15
Compliance with Listing Rules and Corporations Act ................................................... 15
Waive ............................................................................................................................ 15
FORFEITURE OF SHARES ........................................................................................................ 15
7.1
7.2
7.3
7.4
7.5
7.6
7.7
7.8
8.
Lien for Members Debts ............................................................................................... 11
Generally ...................................................................................................................... 11
Exemption ..................................................................................................................... 12
Dividends ...................................................................................................................... 12
Sale of Shares .............................................................................................................. 12
Restrictions on Sale ...................................................................................................... 13
Person Authorised to Sign Transfers ............................................................................ 13
Proceeds of Sale .......................................................................................................... 13
Protection of Lien under ASX Settlement Operating Rules .......................................... 13
Further Powers re Forfeited Shares and Liens ............................................................ 13
Form of Transfer ........................................................................................................... 16
CHESS Transfers ......................................................................................................... 17
Participation in CHESS ................................................................................................. 17
Registration Procedure ................................................................................................. 17
Power to Refuse to Register ......................................................................................... 17
Closure of Register ....................................................................................................... 18
Retention of Transfers by Company ............................................................................. 18
Power to suspend registration of transfers ................................................................... 18
Powers of Attorney ....................................................................................................... 18
Other Securities ............................................................................................................ 18
Branch Register ............................................................................................................ 18
Compliance with ASX Settlement Operating Rules ...................................................... 18
Issuer Sponsored Subregister ...................................................................................... 18
Transferor Holds Shares until Registration of Transfer ................................................ 18
Waive ............................................................................................................................ 19
TRANSMISSION OF SHARES ................................................................................................... 19
9.1
9.2
9.3
Death of Shareholder Leaving a Will ............................................................................ 19
Death or Bankruptcy of Shareholder or the Shareholder becomes of unsound mind .. 19
Registration by Transmission or to Beneficiary ............................................................ 19
ii
9.4
9.5
9.6
9.7
9.8
10.
Limitations to Apply ....................................................................................................... 19
Death of a Joint Holder ................................................................................................. 19
Joint Personal Representatives .................................................................................... 20
ASX Settlement Transfer .............................................................................................. 20
Joint Holders ................................................................................................................. 20
CHANGES TO CAPITAL STRUCTURE ..................................................................................... 20
10.1
10.2
10.3
10.4
Alterations to Capital..................................................................................................... 20
Reduction of Capital ..................................................................................................... 20
Buy-Backs ..................................................................................................................... 20
Fractions ....................................................................................................................... 21
11.
WRITTEN RESOLUTIONS .......................................................................................................... 21
12.
GENERAL MEETINGS ................................................................................................................ 21
12.1
12.2
12.3
12.4
12.5
12.6
12.7
12.8
12.9
13.
Convening of General Meetings of Shareholders by Directors’ Resolution ................. 21
Change of place or postponement of a General Meeting of Shareholders .................. 21
Convening of General Meetings of Shareholders by a Director or requisition ............. 21
Cancellation of a General Meeting of Shareholders ..................................................... 22
Notice ............................................................................................................................ 22
Irregularities in giving notice ......................................................................................... 23
Business at General Meeting ....................................................................................... 23
Notice to Home Branch................................................................................................. 23
Annual General Meeting ............................................................................................... 23
PROCEEDINGS AT GENERAL MEETINGS .............................................................................. 24
13.1
13.2
13.3
13.4
13.5
13.6
13.7
13.8
13.9
13.10
13.11
13.12
13.13
13.14
13.15
13.16
13.17
13.18
13.19
13.20
13.21
13.22
13.23
13.24
13.25
13.26
13.27
13.28
13.29
13.30
13.31
Quorum ......................................................................................................................... 24
Persons Entitled to Attend a General Meeting ............................................................. 24
Refusal of Admission to Meetings ................................................................................ 24
Insufficient room ........................................................................................................... 25
Chairman ...................................................................................................................... 25
Vacating Chair .............................................................................................................. 25
Disputes Concerning Procedure ................................................................................... 25
General Conduct ........................................................................................................... 25
Adjournment ................................................................................................................. 25
Notice of Resumption of Adjourned Meeting ................................................................ 25
How resolutions are decided ........................................................................................ 26
Casting Vote ................................................................................................................. 26
Voting Rights ................................................................................................................ 26
Voting - Show of Hands ................................................................................................ 26
Results of Voting ........................................................................................................... 26
Poll ................................................................................................................................ 26
Manner of Taking Poll ................................................................................................... 27
Meeting May Continue .................................................................................................. 27
Voting by Joint Holders ................................................................................................. 27
Shareholder under Disability ........................................................................................ 27
Payment of Calls ........................................................................................................... 27
Objection to Voting ....................................................................................................... 27
Restrictions on voting ................................................................................................... 27
Proxies .......................................................................................................................... 27
Electronic Appointment of Proxy .................................................................................. 28
Name of proxy .............................................................................................................. 28
Incomplete proxy appointment ..................................................................................... 28
No right to speak or vote if appointing Shareholder present ........................................ 29
Rights where 2 proxies or attorneys are appointed ...................................................... 29
More than 2 proxies or attorneys appointed ................................................................. 29
Proxy Votes .................................................................................................................. 29
iii
13.32
13.33
13.34
14.
THE DIRECTORS ........................................................................................................................ 30
14.1
14.2
14.3
14.4
14.5
14.6
14.7
14.8
14.9
14.10
15.
Convening a Meeting .................................................................................................... 34
Procedure at Meetings.................................................................................................. 34
Quorum ......................................................................................................................... 34
Secretary May Attend and Be Heard ............................................................................ 34
Majority Decisions ......................................................................................................... 34
Casting Votes ............................................................................................................... 35
Alternate Directors ........................................................................................................ 35
Continuing Directors May Act ....................................................................................... 35
Chairman ...................................................................................................................... 35
Committees ................................................................................................................... 36
Written Resolutions ....................................................................................................... 36
Defective Appointment .................................................................................................. 36
Directors May Hold Other Offices ................................................................................. 36
Directors May Hold Shares, etc. ................................................................................... 36
Directors Not Accountable for Benefits ......................................................................... 37
Disclosure of Interests in Related Matters .................................................................... 37
Disclosure of Shareholding ........................................................................................... 37
Related Body Corporate Contracts ............................................................................... 37
Voting, Affixation of Seal............................................................................................... 37
Home Branch to be Advised ......................................................................................... 37
MEETING BY INSTANTANEOUS COMMUNICATION DEVICE ................................................ 38
17.1
17.2
17.3
17.4
18.
Management of the Company ...................................................................................... 32
Borrowings .................................................................................................................... 33
Attorneys ....................................................................................................................... 33
Cheques, etc. ................................................................................................................ 33
Retirement Benefits for Directors ................................................................................. 33
Securities to Directors or Shareholders ........................................................................ 34
PROCEEDINGS OF DIRECTORS .............................................................................................. 34
16.1
16.2
16.3
16.4
16.5
16.6
16.7
16.8
16.9
16.10
16.11
16.12
16.13
16.14
16.15
16.16
16.17
16.18
16.19
16.20
17.
Number of Directors ...................................................................................................... 30
Rotation of Directors ..................................................................................................... 30
Election of Directors ...................................................................................................... 31
Additional Directors ....................................................................................................... 31
Removal of Director ...................................................................................................... 31
Vacation of Office ......................................................................................................... 31
Remuneration ............................................................................................................... 32
Initial Fees to Directors ................................................................................................. 32
Expenses ...................................................................................................................... 32
No Share Qualification .................................................................................................. 32
POWERS AND DUTIES OF DIRECTORS .................................................................................. 32
15.1
15.2
15.3
15.4
15.5
15.6
16.
Representatives of Corporate Shareholders ................................................................ 29
More than one Representative present ........................................................................ 30
Rights of Representatives, proxies and attorneys ........................................................ 30
Meetings to be Effectual ............................................................................................... 38
Procedure at Meetings.................................................................................................. 38
Minutes ......................................................................................................................... 38
Definition ....................................................................................................................... 38
MANAGING AND EXECUTIVE DIRECTORS AND SECRETARIES ......................................... 39
18.1
18.2
18.3
Appointment .................................................................................................................. 39
Remuneration ............................................................................................................... 39
Powers .......................................................................................................................... 39
iv
18.4
18.5
19.
SEALS ......................................................................................................................................... 39
19.1
19.2
19.3
20.
Authorisation of Dividend Reinvestment Plan .............................................................. 44
Amendment and Revocation ........................................................................................ 44
NOTICES ..................................................................................................................................... 44
26.1
26.2
26.3
26.4
26.5
26.6
26.7
26.8
26.9
27.
Authorisation of Bonus Share Plan ............................................................................... 44
Amendment and Revocation ........................................................................................ 44
DIVIDEND REINVESTMENT PLAN ............................................................................................ 44
25.1
25.2
26.
Capitalisation ................................................................................................................ 43
Application of Capitalised Amounts .............................................................................. 43
Procedures ...........................................................................................................
Share your feedback
Discover